DTIL
DTIL clinical trials: PRECISION BIOSCIENCES INC
Every trial on ClinicalTrials.gov where PRECISION BIOSCIENCES INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 12
- Trials linked
- 11
- As lead sponsor
- 1
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
DTIL on the catalyst calendar · DTIL registry changes
- Primary completion Nov 2029Sponsor estimatePhase 1/Phase 2NCT07429240PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)Precision BioSciences, Inc. · Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMDRecruitingDTILLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 1NCT06680232Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis BPrecision BioSciences, Inc. · HEPATITIS B CHRONICRecruitingDTILLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 17, 2026ActualPhase 1/Phase 2NCT03476681Study of NEO-201 in Solid Tumors Expansion CohortsPrecision Biologics, Inc · Non Small Cell Lung CancerActive, not recruitingDTILLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2040Sponsor estimateNo phase registeredNCT07254208A Long-term Observational Study in Participants Who Have Received PBGENE-HBVPrecision BioSciences, Inc. · Chronic HBV InfectionEnrolling by invitationDTILLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 1, 2019ActualPhase 1NCT07271446An Autologous NK/CIK Cell Product (PB101) in Combination With EGFR-TKI for Treating Lung CancerPrecision Biotech Taiwan Corp. · Non-small Cell Lung CancerCompletedDTILLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 13, 2017ActualPhase 1/Phase 2NCT01834235QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic CancerPrecision Biologics, Inc · Pancreatic Cancer, AdultTerminatedDTILLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 30, 2027Sponsor estimatePhase 1/Phase 2NCT04616209Allogeneic PB103 (NK Cells) Therapy in Non-small Cell Lung Cancer (NSCLC) PatientsPrecision Biotech Taiwan Corp. · Non-small Cell Lung CancerRecruitingDTILLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 22, 2022ActualPhase 1NCT04649112Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing MalignanciesPrecision BioSciences, Inc. · CD19 Expressing MalignanciesCompletedDTILLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 19, 2022ActualPhase 1NCT04171843A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants...Precision BioSciences, Inc. · Relapsed/Refractory Multiple MyelomaTerminatedDTILLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 24, 2021ActualPhase 1/Phase 2NCT04030195Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLLPrecision BioSciences, Inc. · Non-Hodgkin's Lymphoma, RelapsedCompletedDTILLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2017ActualPhase 1/Phase 2NCT01040000QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal CancerPrecision Biologics, Inc · Metastatic Pancreatic CancerCompletedDTILLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2021Sponsor estimateNo phase registeredNCT04493307The Evaluation of Hemostasis in Hospitalized COVID-19 PatientsLifeBridge Health · COVID-19Unknown statusHAECollaboratorDTILCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 12 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner